{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:48:15Z","timestamp":1794962895440,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T00:00:00Z","timestamp":1656892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HL147883"],"award-info":[{"award-number":["HL147883"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Heart failure with preserved ejection fraction (HFpEF) exhibits a sex bias, being more common in women than men, and we hypothesize that mitochondrial sex differences might underlie this bias. As part of genetic studies of heart failure in mice, we observe that heart mitochondrial DNA levels and function tend to be reduced in females as compared to males. We also observe that expression of genes encoding mitochondrial proteins are higher in males than females in human cohorts. We test our hypothesis in a panel of genetically diverse inbred strains of mice, termed the Hybrid Mouse Diversity Panel (HMDP). Indeed, we find that mitochondrial gene expression is highly correlated with diastolic function, a key trait in HFpEF. Consistent with this, studies of a \u201ctwo-hit\u201d mouse model of HFpEF confirm that mitochondrial function differs between sexes and is strongly associated with a number of HFpEF traits. By integrating data from human heart failure and the mouse HMDP cohort, we identify the mitochondrial gene\n                    <jats:italic>Acsl6<\/jats:italic>\n                    as a genetic determinant of diastolic function. We validate its role in HFpEF using adenoviral over-expression in the heart. We conclude that sex differences in mitochondrial function underlie, in part, the sex bias in diastolic function.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-31544-5","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T13:07:05Z","timestamp":1656940025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Sex differences in heart mitochondria regulate diastolic dysfunction"],"prefix":"10.1038","volume":"13","author":[{"given":"Yang","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Vergnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0752-833X","authenticated-orcid":false,"given":"Calvin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthickeyan","family":"Chella Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4250-3370","authenticated-orcid":false,"given":"Timothy M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2169-3972","authenticated-orcid":false,"given":"Manuel","family":"Rosa-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd H.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarada","family":"Charugundla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph D.","family":"Rau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8026-4759","authenticated-orcid":false,"given":"Marcus M.","family":"Seldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7348-0509","authenticated-orcid":false,"given":"Jessica","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0852-0767","authenticated-orcid":false,"given":"Yibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Vondriska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Reue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9013-0228","authenticated-orcid":false,"given":"Aldons J.","family":"Lusis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,4]]},"reference":[{"key":"31544_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","volume":"14","author":"SM Dunlay","year":"2017","unstructured":"Dunlay, S. M., Roger, V. L. & Redfield, M. M. Epidemiology of heart failure with preserved ejection fraction. Nat. Rev. Cardiol. 14, 591\u2013602 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"31544_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jjcc.2013.02.017","volume":"62","author":"H Iwano","year":"2013","unstructured":"Iwano, H. & Little, W. C. Heart failure: what does ejection fraction have to do with it? J. Cardiol. 62, 1\u20133 (2013).","journal-title":"J. Cardiol."},{"key":"31544_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/heartjnl-2017-311652","volume":"104","author":"SL Zheng","year":"2018","unstructured":"Zheng, S. L. et al. Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Heart 104, 407\u2013415 (2018).","journal-title":"Heart"},{"key":"31544_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jacc.2003.07.046","volume":"43","author":"K Hogg","year":"2004","unstructured":"Hogg, K., Swedberg, K. & McMurray, J. Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J. Am. Coll. Cardiol. 43, 317\u2013327 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"31544_CR5","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1161\/CIRCRESAHA.118.313568","volume":"124","author":"IY Elgendy","year":"2019","unstructured":"Elgendy, I. Y., Mahtta, D. & Pepine, C. J. Medical therapy for heart failure caused by ischemic heart disease. Circ. Res. 124, 1520\u20131535 (2019).","journal-title":"Circ. Res."},{"key":"31544_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan, T. E. et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 355, 251\u2013259 (2006).","journal-title":"N. Engl. J. Med"},{"key":"31544_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/eurjhf\/hfq121","volume":"13","author":"CS Lam","year":"2011","unstructured":"Lam, C. S., Donal, E., Kraigher-Krainer, E. & Vasan, R. S. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur. J. Heart Fail 13, 18\u201328 (2011).","journal-title":"Eur. J. Heart Fail"},{"key":"31544_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ahj.2014.07.008","volume":"168","author":"RK Cheng","year":"2014","unstructured":"Cheng, R. K. et al. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am. Heart J. 168, 721\u2013730 (2014).","journal-title":"Am. Heart J."},{"key":"31544_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19507-7","volume":"8","author":"F Duca","year":"2018","unstructured":"Duca, F. et al. Gender-related differences in heart failure with preserved ejection fraction. Sci. Rep. 8, 1080 (2018).","journal-title":"Sci. Rep."},{"key":"31544_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","volume":"138","author":"AL Beale","year":"2018","unstructured":"Beale, A. L., Meyer, P., Marwick, T. H., Lam, C. S. P. & Kaye, D. M. Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction. Circulation 138, 198\u2013205 (2018).","journal-title":"Circulation"},{"key":"31544_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13293-019-0223-0","volume":"10","author":"EL Kessler","year":"2019","unstructured":"Kessler, E. L., Rivaud, M. R., Vos, M. A. & van Veen, T. A. B. Sex-specific influence on cardiac structural remodeling and therapy in cardiovascular disease. Biol. Sex. Differ. 10, 7 (2019).","journal-title":"Biol. Sex. Differ."},{"key":"31544_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/jocs.12506","volume":"30","author":"RG Ferreira","year":"2015","unstructured":"Ferreira, R. G., Worthington, A., Huang, C. C., Aranki, S. F. & Muehlschlegel, J. D. Sex differences in the prevalence of diastolic dysfunction in cardiac surgical patients. J. Card. Surg. 30, 238\u2013245 (2015).","journal-title":"J. Card. Surg."},{"key":"31544_CR13","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","volume":"34","author":"FP Brouwers","year":"2013","unstructured":"Brouwers, F. P. et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur. Heart J. 34, 1424\u20131431 (2013).","journal-title":"Eur. Heart J."},{"key":"31544_CR14","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1161\/CIRCULATIONAHA.117.031622","volume":"137","author":"A Pandey","year":"2018","unstructured":"Pandey, A. et al. Sex and race differences in lifetime risk of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. Circulation 137, 1814\u20131823 (2018).","journal-title":"Circulation"},{"key":"31544_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","volume":"6","author":"JE Ho","year":"2013","unstructured":"Ho, J. E. et al. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ. Heart Fail 6, 279\u2013286 (2013).","journal-title":"Circ. Heart Fail"},{"key":"31544_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/sj.jhh.1000689","volume":"12","author":"B Kuch","year":"1998","unstructured":"Kuch, B. et al. Gender specific differences in left ventricular adaptation to obesity and hypertension. J. Hum. Hypertens. 12, 685\u2013691 (1998).","journal-title":"J. Hum. Hypertens."},{"key":"31544_CR17","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.105.541078","volume":"112","author":"MM Redfield","year":"2005","unstructured":"Redfield, M. M., Jacobsen, S. J., Borlaug, B. A., Rodeheffer, R. J. & Kass, D. A. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 112, 2254\u20132262 (2005).","journal-title":"Circulation"},{"key":"31544_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1101\/gr.099234.109","volume":"20","author":"BJ Bennett","year":"2010","unstructured":"Bennett, B. J. et al. A high-resolution association mapping panel for the dissection of complex traits in mice. Genome Res. 20, 281\u2013290 (2010).","journal-title":"Genome Res"},{"key":"31544_CR19","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1194\/jlr.R066944","volume":"57","author":"AJ Lusis","year":"2016","unstructured":"Lusis, A. J. et al. The Hybrid Mouse Diversity Panel: a resource for systems genetics analyses of metabolic and cardiovascular traits. J. Lipid Res. 57, 925\u2013942 (2016).","journal-title":"J. Lipid Res."},{"key":"31544_CR20","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1534\/g3.115.020784","volume":"5","author":"CD Rau","year":"2015","unstructured":"Rau, C. D. et al. High-density genotypes of inbred mouse strains: improved power and precision of association mapping. G3 (Bethesda) 5, 2021\u20132026 (2015).","journal-title":"G3 (Bethesda)"},{"key":"31544_CR21","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1161\/CIRCULATIONAHA.119.042267","volume":"140","author":"D Tong","year":"2019","unstructured":"Tong, D. et al. Female sex is protective in a preclinical model of heart failure with preserved ejection fraction. Circulation 140, 1769\u20131771 (2019).","journal-title":"Circulation"},{"key":"31544_CR22","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.cmet.2018.12.013","volume":"29","author":"F Norheim","year":"2019","unstructured":"Norheim, F. et al. Gene-by-sex interactions in mitochondrial functions and cardio-metabolic traits. Cell Metab. 29, 932\u2013949 (2019). e934.","journal-title":"Cell Metab."},{"key":"31544_CR23","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.118.036259","volume":"139","author":"AA Kumar","year":"2019","unstructured":"Kumar, A. A., Kelly, D. P. & Chirinos, J. A. Mitochondrial dysfunction in heart failure with preserved ejection fraction. Circulation 139, 1435\u20131450 (2019).","journal-title":"Circulation"},{"key":"31544_CR24","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/CIRCHEARTFAILURE.112.000228","volume":"6","author":"L Zhang","year":"2013","unstructured":"Zhang, L. et al. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Circ. Heart Fail 6, 1039\u20131048 (2013).","journal-title":"Circ. Heart Fail"},{"key":"31544_CR25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-1-4939-1875-1_3","volume":"1241","author":"JP Rooney","year":"2015","unstructured":"Rooney, J. P. et al. PCR based determination of mitochondrial DNA copy number in multiple species. Methods Mol. Biol. 1241, 23\u201338 (2015).","journal-title":"Methods Mol. Biol."},{"key":"31544_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-1-61779-504-6_22","volume":"837","author":"V Venegas","year":"2012","unstructured":"Venegas, V. & Halberg, M. C. Measurement of mitochondrial DNA copy number. Methods Mol. Biol. 837, 327\u2013335 (2012).","journal-title":"Methods Mol. Biol."},{"key":"31544_CR27","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3389\/fendo.2018.00732","volume":"9","author":"C John","year":"2018","unstructured":"John, C. et al. Sex differences in cardiac mitochondria in the New Zealand obese mouse. Front. Endocrinol. (Lausanne) 9, 732 (2018).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"31544_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10591-5","volume":"10","author":"P Cordero","year":"2019","unstructured":"Cordero, P. et al. Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failure. Nat. Commun. 10, 2760 (2019).","journal-title":"Nat. Commun."},{"key":"31544_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","volume":"568","author":"GG Schiattarella","year":"2019","unstructured":"Schiattarella, G. G. et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature 568, 351\u2013356 (2019).","journal-title":"Nature"},{"key":"31544_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2466\/pr0.1968.22.2.547","volume":"22","author":"JW Kakolewski","year":"1968","unstructured":"Kakolewski, J. W., Cox, V. C. & Valenstein, E. S. Sex differences in body-weight change following gonadectomy of rats. Psychol. Rep. 22, 547\u2013554 (1968).","journal-title":"Psychol. Rep."},{"key":"31544_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng.3506","volume":"48","author":"A Gusev","year":"2016","unstructured":"Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245\u2013252 (2016).","journal-title":"Nat. Genet."},{"key":"31544_CR32","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker, S. D. et al. Empagliflozin in heart failure with a preserved ejection fraction. N. Engl. J. Med. 385, 1451\u20131461 (2021).","journal-title":"N. Engl. J. Med."},{"key":"31544_CR33","unstructured":"Abdellatif, M. et al. Nicotinamide for the treatment of heart failure with preserved ejection fraction. Sci. Transl. Med. 13, eabd7064 (2021)."},{"key":"31544_CR34","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1161\/CIRCRESAHA.120.317046","volume":"128","author":"D Tong","year":"2021","unstructured":"Tong, D. et al. NAD(+) repletion reverses heart failure with preserved ejection fraction. Circ. Res. 128, 1629\u20131641 (2021).","journal-title":"Circ. Res"},{"key":"31544_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/cvr\/cvaa217","volume":"117","author":"GG Schiattarella","year":"2021","unstructured":"Schiattarella, G. G., Rodolico, D. & Hill, J. A. Metabolic inflammation in heart failure with preserved ejection fraction. Cardiovasc. Res. 117, 423\u2013434 (2021).","journal-title":"Cardiovasc. Res."},{"key":"31544_CR36","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1093\/eurheartj\/ehab389","volume":"42","author":"C Withaar","year":"2021","unstructured":"Withaar, C., Lam, C. S. P., Schiattarella, G. G., de Boer, R. A. & Meems, L. M. G. Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models. Eur. Heart J. 42, 4420\u20134430 (2021).","journal-title":"Eur. Heart J."},{"key":"31544_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21931-9","volume":"12","author":"GG Schiattarella","year":"2021","unstructured":"Schiattarella, G. G. et al. Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction. Nat. Commun. 12, 1684 (2021).","journal-title":"Nat. Commun."},{"key":"31544_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bbrc.2021.07.090","volume":"572","author":"H Kitakata","year":"2021","unstructured":"Kitakata, H. et al. Imeglimin prevents heart failure with preserved ejection fraction by recovering the impaired unfolded protein response in mice subjected to cardiometabolic stress. Biochem. Biophys. Res. Commun. 572, 185\u2013190 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"31544_CR39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/978-3-319-77932-4_32","volume":"1065","author":"G Savarese","year":"2018","unstructured":"Savarese, G. & D\u2019Amario, D. Sex differences in heart failure. Adv. Exp. Med. Biol. 1065, 529\u2013544 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"31544_CR40","doi-asserted-by":"crossref","unstructured":"Tadic, M. et al. Sex and heart failure with preserved ejection fraction: from pathophysiology to clinical studies. J. Clin. Med. 8, 792 (2019).","DOI":"10.3390\/jcm8060792"},{"key":"31544_CR41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown, D. A. et al. Expert consensus document: mitochondrial function as a therapeutic target in heart failure. Nat. Rev. Cardiol. 14, 238\u2013250 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"31544_CR42","doi-asserted-by":"publisher","first-page":"e0206003","DOI":"10.1371\/journal.pone.0206003","volume":"13","author":"P Yue","year":"2018","unstructured":"Yue, P. et al. Association between mitochondrial DNA copy number and cardiovascular disease: current evidence based on a systematic review and meta-analysis. PLoS ONE 13, e0206003 (2018).","journal-title":"PLoS ONE"},{"key":"31544_CR43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fendo.2020.00110","volume":"11","author":"J Tao","year":"2020","unstructured":"Tao, J., Liu, X. & Bai, W. Testosterone supplementation in patients with chronic heart failure: a meta-analysis of randomized controlled trials. Front. Endocrinol. (Lausanne) 11, 110 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"31544_CR44","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cmet.2015.01.002","volume":"21","author":"BW Parks","year":"2015","unstructured":"Parks, B. W. et al. Genetic architecture of insulin resistance in the mouse. Cell Metab. 21, 334\u2013347 (2015).","journal-title":"Cell Metab."},{"key":"31544_CR45","doi-asserted-by":"publisher","first-page":"e21746","DOI":"10.1371\/journal.pone.0021746","volume":"6","author":"GW Rogers","year":"2011","unstructured":"Rogers, G. W. et al. High throughput microplate respiratory measurements using minimal quantities of isolated mitochondria. PLoS ONE 6, e21746 (2011).","journal-title":"PLoS ONE"},{"key":"31544_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yjmcc.2021.07.002","volume":"160","author":"DJ Chapski","year":"2021","unstructured":"Chapski, D. J. et al. Early adaptive chromatin remodeling events precede pathologic phenotypes and are reinforced in the failing heart. J. Mol. Cell Cardiol. 160, 73\u201386 (2021).","journal-title":"J. Mol. Cell Cardiol."},{"key":"31544_CR47","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.117.029430","volume":"136","author":"M Rosa-Garrido","year":"2017","unstructured":"Rosa-Garrido, M. et al. High-resolution mapping of chromatin conformation in cardiac myocytes reveals structural remodeling of the epigenome in heart failure. Circulation 136, 1613\u20131625 (2017).","journal-title":"Circulation"},{"key":"31544_CR48","doi-asserted-by":"publisher","first-page":"20676","DOI":"10.1016\/S0021-9258(20)80777-7","volume":"268","author":"CC Hedrick","year":"1993","unstructured":"Hedrick, C. C., Castellani, L. W., Warden, C. H., Puppione, D. L. & Lusis, A. J. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. J. Biol. Chem. 268, 20676\u201320682 (1993).","journal-title":"J. Biol. Chem."},{"key":"31544_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-426","volume":"8","author":"BT Sherman","year":"2007","unstructured":"Sherman, B. T. et al. DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinforma. 8, 426 (2007).","journal-title":"BMC Bioinforma."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31544-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31544-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31544-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T12:57:06Z","timestamp":1669294626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-31544-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,4]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["31544"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-31544-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,4]]},"assertion":[{"value":"27 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3850"}}